Cidara Therapeutics Inc. (NASDAQ: CDTX) Stock Information | RedChip

Cidara Therapeutics Inc. (NASDAQ: CDTX) Listen to this Section


$12.50
-0.1400 ( -1.11% ) 11.7K

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Market Data


Open


$12.50

Previous close


$12.64

Volume


11.7K

Market cap


$90.02M

Day range


$12.45 - $12.83

52 week range


$10.00 - $24.40

Insider Ownership Transactions

Total Amount Purchased: -1,517,750.00 | $ -18,971,875.00

Date Type Amount Purchased Purchaser
2024-06-11 Buy 8000.00 Stein Jeffrey
2024-04-30 Sale -4250.00 RA CAPITAL MANAGEMENT, L.P.
2024-04-30 Sale -4250.00 Spencer Ryan
2024-04-30 Sale -4250.00 Merson James
2024-04-30 Sale -4250.00 Tadvalkar Laura
2024-03-20 Sale -120000.00 Ward Shane
2024-03-20 Sale -108750.00 Shah Preetam
2024-03-20 Sale -111250.00 Tari Leslie
2024-03-20 Sale -128750.00 Sandison Taylor
2024-03-20 Sale -1040000.00 Stein Jeffrey

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jul 19, 2024
4 Insider transactions 1 Jul 19, 2024
4 Insider transactions 1 Jul 19, 2024
8-k 8K-related 15 Jul 18, 2024
4 Insider transactions 1 Jun 11, 2024
ars Annual reports 1 Jun 03, 2024
def Proxies and info statements 8 Jun 03, 2024
pre Proxies and info statements 4 May 23, 2024
8-k 8K-related 13 May 20, 2024
10-q Quarterly Reports 74 May 15, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.